Genomics

Dataset Information

0

Aberrant hyperediting of myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

ABSTRACT: Aberrant hyperediting of myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

PROVIDER: PRJNA433846 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR6710120_1.fastq.gz Fastqsanger.gz
SRR6710120_2.fastq.gz Fastqsanger.gz
SRR6710130_1.fastq.gz Fastqsanger.gz
SRR6710130_2.fastq.gz Fastqsanger.gz
SRR6710121_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 46

Similar Datasets

Other Aberrant hyperediting of myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis
2018-09-27 | GSE110486 | GEO
Genomics Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
| PRJNA499054 | ENA
Genomics Distinct gene expression profile between ARID1Ahigh and good prognosis and ARID1Alow and poor prognosis groups
| PRJNA432896 | ENA
Transcriptomics Distinct gene expression profile between ARID1Ahigh and good prognosis and ARID1Alow and poor prognosis groups
2018-02-06 | GSE110078 | GEO
Genomics Elevated PRKD2 Promotes Progression and Poor Prognosis of Multiple Myeloma
| PRJNA1117013 | ENA
Genomics MYC regulation of a "poor prognosis" metastatic cancer cell state
| PRJNA111899 | ENA
Genomics Secretory IgA dysfunction underlies poor prognosis in Fusobacterium-infected colorectal cancer
| PRJNA1142424 | ENA
Genomics Gastric and esophagogastric junction adenocarcinoma with infrequent hypermethylation show poor prognosis
| PRJNA857438 | ENA
Genomics Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma
| PRJNA1051149 | ENA
Genomics RIPK2-Regulated Gene Signature Associated with Poor Prognosis in Prostate Cancer
| PRJNA1237822 | ENA